Numab Therapeutics is a series b startup. 1 investor tracked. Status: possibledead.
Based in Switzerland, Numab Therapeutics is a startup. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
Numab Therapeutics is a biopharmaceutical company discovering and developing a new class of antibody therapeutics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.